6. Carotid Body Tumors: Surgical Treatment And Perioperative Risk Factors Of Adverse Events

Authors

  • T.K. Tajibayev «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • M.B. Kamal «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • A.Zh. Matkerimov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • E.A. Yenin «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • A.S. Tergeussizov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • A.A. Baubekov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • T.N. Demeuov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • M.A. Zhakubaev «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • R.O. Makkamov «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • A.Ye. Saduakas «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ
  • N.N. Erkinbayev «A.N. Syzganov National Scientific Center for Surgery» JSC, Almaty, Kazakhstan, ғылыми хирургия орталығы» АҚ

Downloads

Abstract

A carotid body tumor (CBT), also commonly known as nonchromaffin paragangliomas and chemodectomas, is a slowly growing neoplasm originating from carotid body chemoreceptors. Objectives: To present the possible predic-tors of adverse events in the treatment of carotid body tumors..

Materials and methods. The study was performed on basis of Scientific Central Surgery named after A. N. Syzganov. Only 8 patients with 8 tumors who underwent open surgical treatment of CBT over the past 10 years (from 2009 to 2019)..

Results. 6 (75%) patients had a painless mass in the neck, and 2 (25%) painful. According to the results of CTA and arteriography, the patients were classified according to the Shamblin classification (Figure 1), of which 1 patient had the I type of tumor (12.5%), type II in three (37.5%) and type III (50%) 4 patients, one (12%) of which revealed hemodynamically significant stenosis of bifurcation of the com-mon carotid artery (CCA). The average number of days a patient was in the hospital stay increased direct proportional difference and the type of tumor. The time and approach of the operation, intraoperative blood loss, the volume of blood transfusion increased in the same way as the size of the tumor increased, involvement of the carotid artery and malignancy of the tumors. One patient had a cranial nerve injury (temporal), which resolved after additional treatment. Pathology results showed that two patients (25%) had malignant cells in the tumor and one of them located in the lymph nodes..

Conclusion. A rare occurrence, slow growth, asymptomatic course and a limited amount of information on the detection and management of the disease lead to an underestimation of the condition. In addition, the large size of the tumor, the involvement of the carotid arteries and cranial nerves in the process directly affect the surgical approach and increase the risk of complications.

Keywords

carotid body tumor, chemo-dectoma, neck paraganglioma, vascular formation, surgical treatment

References

  1. Ward PH, Jenkins HA, Hanafee WN. Diagnosis and treatment of carotid body tumors. Ann Otol Rhinol Laryngol 1978;87:614-21
  2. Wang S.J., Wang M.B., Barauskas T.M., Calcaterra T.C. Surgical management of carotid body tumors. Otolaryngol Head Neck Surg 2000;123:202–6
  3. Pryse-Davies J., Dawson I.P., Westbury G. Some morphologic, histochemical, and chemical obser-vations on chemodectomas and the normal carotid body, including a study of the chromaffin reac-tion and possible ganglion cell elements. Cancer 1964:17:185–202
  4. Mitchell R.O., Richardson J.D., Lamberth G.E. Char-ecteristics, surgical management and outcome in 17 carotid body tumor. Am Surg 1996;62:1034–7
  5. Lahey F.M., Warren K.V. Tumor of carotid body. Surg Gynecol Obstet 1947; 85:281–8
  6. Byrne J.J. Carotide body and allied tumor. Am J Surg 1958;95:371–84 PERIOPERATIVE RISK FACTORS OF ADVERSE EVENTS
  7. Scudder C.L. Tumor of the inter carotid body. A re-port of one case, together with one case in the litera-ture. Am J Med Sci 1903;126:384–9
  8. McPhersen G.A., Hallyday A.W., Mansfield A.O. Carotid body tumor and other paragangliomas: di-agnosis and management in 25 pations. Br J Surg 1989;76:33–6
  9. Robison J.G., Shagets F.V., Becket W.C., Spies J.B. A multidisciplinary approach to reducing morbidity and operative blood loss during resection carotid body tumor. Surg Gynicol Obstet 1986;168:166–70
  10. Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma): clini-copathologic analysis of ninety cases. Am J Surg 1971;122:732-9
  11. Williams MD, Phillips MJ, Rainer WG. Carotid body tumor. Arch Surg 1992;127:963-8
  12. Nora JD, Hallett JW Jr, O’Brien PC, Naessens JM, Cherry KJ, Pairolero PC. Surgical resection of carotid body tumors: long-term survival, recurrence, and metastasis. Mayo Clin Proc 1988;63:348-52
  13. Daudi FA, Thurston OG. Carotid body tumours: the University of Alberta experience. Can J Surg 1989;32:159-61
  14. Bemard RP. Carotid body tumors. Am J Surg 1992;163:494-6
  15. Muhm M, Polterauer P, Gstottner W, Temmel A, Richling B, Undt G, et al. Diagnostic and therapeutic approaches to carotid body tumors. Arch Surg 1997;132:279-84
  16. Li J, Wang S, Zee C, Yang J, Chen W, Zhuang W, et al. Preoperative angiography and transarterial em-bolization in the management of carotid body tumor: a single-center, 10-year experience. Neurosurgery 2010;67:941-8
  17. Makeieff M, Raingeard I, Alric P, Bonafe A, Guerrier B, Marty-Ane C. Surgical management of carotid body tumors. Ann Surg Oncol 2008; 15:2180-6
  18. Woolen S, Gemmete JJ. Paragangliomas of the head andneck. Tinnitus Imaging Endovasc Surg Approach-es 2016;26:259e78
  19. Werter I, Rustemeijer C. Head and neck paragan-gliomas. Land Double-Blind Stud Case Rep King 2013;500:508
  20. Lim JY, Kim J, Kim SH, Lee S, Lim YC, Kim JW, et al. Surgical treatment of carotid body paraganglio-mas: outcomes and complications according to the Shamblin classification. Clin Exp Otorhinolaryngol 2010;3:91-5
  21. Kim et al. New predictors of complications in carotid body tumor resection. Journal of Vascular Surgery 2017 Volume 65, Number 6 ;: 1673-1678
  22. Hallett JW Jr, Nora JD, Hollier LH, Cherry KJ Jr, Pai-rolero PC. Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tu-mors. J Vasc Surg 1988;7:284

Published

2021-08-20

Issue

No. 2 (2021)

Section

Статьи